Abstract

Vol. 118, No. 12 PerspectivesOpen AccessPBDE Flame Retardants and Thyroid Hormones during Pregnancy Julie E. Goodman, Laura E. Kerper, Giffe T. Johnson, Raymond D. Harbison, Rocio Cordero, Richard V. Lee, Milo F. Pulde, Marcia Hardy, and Todd Stedeford Julie E. Goodman Search for more papers by this author , Laura E. Kerper Search for more papers by this author , Giffe T. Johnson Search for more papers by this author , Raymond D. Harbison Search for more papers by this author , Rocio Cordero Search for more papers by this author , Richard V. Lee Search for more papers by this author , Milo F. Pulde Search for more papers by this author , Marcia Hardy Search for more papers by this author , and Todd Stedeford Search for more papers by this author Published:1 December 2010https://doi.org/10.1289/ehp.1002782AboutSectionsPDF ToolsDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InReddit Chevrier et al. (2010) assessed the association between 10 polybrominated diphenylethers (PBDEs) and free and total thyroxine (T4) and thyroid-stimulating hormone (TSH) in 270 women around the 27th week of gestation. They concluded that PBDEs are associated with lower TSH levels during pregnancy, but several factors that likely influenced the results were not considered in their analysis.Normal pregnancy can lead to low TSH levels without affecting T4 levels, as can several other factors (e.g., starvation; stress; psychiatric disorders; depression; acute or chronic nonthyroidal disorders; alterations in thyrotropin- releasing hormone, cortisol, opiodergic, dopaminergic, or somatostatinergic activity; and alterations in leptin and cytokine production) (Braverman and Utiger 2000; Krassas et al. 2010). None of these were included in the analyses of Chevrier et al. (2010), yet any of them could have contributed to lower TSH levels.Chevrier et al. (2010) classified women in their second and third trimesters as having subclinical hyperthyroidism if their serum TSH levels were < 0.5 mIU/L and < 0.8 mIU/L, respectively. Krassas et al. (2010) recently reported TSH reference ranges: 5th percentiles for the second and third trimesters were 0.03–0.39 and 0.13 mIU/L, respectively, suggesting that the cutoffs used by Chevrier et al. (2010) led to an incorrect classification of at least some women.Chevrier et al. (2010) reported that blood was drawn at 27.3 ± 3.1 (mean ± SD) weeks gestation; however, it is unclear which women were in the second trimester and which were in the third trimester. Although Chevrier et al. (2010) adjusted for gestational age, the use of different cutoffs for a binary variable (subclinical hyperthyroidism) for women in the same analyses likely biased results, particularly considering that differences between women near the end of the second and beginning of the third trimester are not great.With the exception of a few outliers, the range of each PBDE among study subjects was quite small (all with the ratio of the 75th to the 25th percentile < 3.4). Because blood was drawn only once and all associations noted were quite weak, even a small difference between the measured PBDE level and the actual level in an individual could have biased the results.All of the PBDE congeners were moderately to strongly intercorrelated (r = 0.6–0.9; p < 0.001), yet analyses were conducted only by individual congener, leaving the inappropriate impression that several of the PBDE congeners may have been causally associated with lower TSH levels.The limitations discussed above preclude one from drawing conclusions regarding associations between serum PBDEs and TSH. It is notable, however, that even if associations are shown to be causal, the decrements in TSH reported are very small and mostly within the reference range for pregnant women. Thus, they are unlikely to result in adverse health effects in either pregnant women or their fetuses.ReferencesBraverman LE, Utiger RD. 2000. Werner & Ingbar’s The Thyroid: A Fundamental and Clinical Text8th edPhiladelphiaLippincott Williams & Wilkins. Google ScholarChevrier J, Harley KG, Bradman A, Gharbi M, Sjödin A, Eskenazi B. 2010. Polybrominated diphenylether (PBDE) flame retardants and thyroid hormone during pregnancy. Environ Health Perspect 118:1444-1449doi:10.1289/ehp.100190520562054. Link, Google ScholarKrassas GE, Poppe K, Glinoer D. 2010. Thyroid function and human reproductive health. Endocr Revdoi:10.1210/er.2009-0041[Online 23 June 2010]. Crossref, Medline, Google ScholarFiguresReferencesRelatedDetails Vol. 118, No. 12 December 2010Metrics About Article Metrics Publication History Originally published1 December 2010Published in print1 December 2010 Financial disclosuresPDF download License information EHP is an open-access journal published with support from the National Institute of Environmental Health Sciences, National Institutes of Health. All content is public domain unless otherwise noted. Note to readers with disabilities EHP strives to ensure that all journal content is accessible to all readers. However, some figures and Supplemental Material published in EHP articles may not conform to 508 standards due to the complexity of the information being presented. If you need assistance accessing journal content, please contact [email protected]. Our staff will work with you to assess and meet your accessibility needs within 3 working days.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.